Guard Therapeutics International AB (publ) - ESG Rating & Company Profile powered by AI
This analysis of Guard Therapeutics International AB (publ) was assembled by All Street Sevva using cutting edge AI. The webpage is a free ESG analysis for Guard Therapeutics International AB (publ). The SDG rating for Guard Therapeutics International AB (publ) represents its transparency towards the UN Sustainable Development Goals.
Guard Therapeutics International AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 8.0, social score of 2.7 and governance score of 2.7.
4.5
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
852 | Vaccibody AS | 4.6 | High |
852 | argenx SE | 4.6 | High |
868 | Guard Therapeutics International AB (publ) | 4.5 | High |
868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
868 | Boiron SA | 4.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Guard Therapeutics International AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Does Guard Therapeutics International AB (publ) disclose current and historical energy intensity?
Does Guard Therapeutics International AB (publ) report the average age of the workforce?
Does Guard Therapeutics International AB (publ) reference operational or capital allocation in relation to climate change?
Does Guard Therapeutics International AB (publ) disclose its ethnicity pay gap?
Does Guard Therapeutics International AB (publ) disclose cybersecurity risks?
Does Guard Therapeutics International AB (publ) offer flexible work?
Does Guard Therapeutics International AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Guard Therapeutics International AB (publ) disclose the number of employees in R&D functions?
Does Guard Therapeutics International AB (publ) conduct supply chain audits?
Does Guard Therapeutics International AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Guard Therapeutics International AB (publ) conduct 360 degree staff reviews?
Does Guard Therapeutics International AB (publ) disclose the individual responsible for D&I?
Does Guard Therapeutics International AB (publ) disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Guard Therapeutics International AB (publ) disclose current and / or historical scope 2 emissions?
Does Guard Therapeutics International AB (publ) disclose water use targets?
Does Guard Therapeutics International AB (publ) have careers partnerships with academic institutions?
Did Guard Therapeutics International AB (publ) have a product recall in the last two years?
Does Guard Therapeutics International AB (publ) disclose incidents of discrimination?
Does Guard Therapeutics International AB (publ) allow for Work Councils/Collective Agreements to be formed?
Has Guard Therapeutics International AB (publ) issued a profit warning in the past 24 months?
Does Guard Therapeutics International AB (publ) disclose parental leave metrics?
Does Guard Therapeutics International AB (publ) disclose climate scenario or pathway analysis?
Does Guard Therapeutics International AB (publ) disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Guard Therapeutics International AB (publ) disclose the pay ratio of women to men?
Does Guard Therapeutics International AB (publ) support suppliers with sustainability related research and development?
Does Guard Therapeutics International AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Guard Therapeutics International AB (publ) reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Guard Therapeutics International AB (publ) involved in embryonic stem cell research?
Does Guard Therapeutics International AB (publ) disclose GHG and Air Emissions intensity?
Does Guard Therapeutics International AB (publ) disclose its waste policy?
Does Guard Therapeutics International AB (publ) report according to TCFD requirements?
Does Guard Therapeutics International AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Guard Therapeutics International AB (publ) disclose energy use targets?
Does Guard Therapeutics International AB (publ) disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Guard Therapeutics International AB (publ) have a policy relating to cyber security?
Have a different question?
Potential Risks for Guard Therapeutics International AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.